Rozanolixizumab improved muscle weakness and fatigue in myasthenia gravis patients, as shown in the MycarinG study using MG Symptoms PRO scales. Strong correlations were found between MG Symptoms PRO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback